The World Health Organization (WHO) will meet next week with an independent group of experts to take a final decision on whether to grant Emergency Use Listing (EUL) to Covaxin. The WHO will carry out the risk and benefit assessments next week with the experts and take a final call on granting the much-awaited EUL to Covid vaccine Covaxin.

The global health body said, "WHO and an independent group of experts are scheduled to meet next week to carry out the risk/benefit assessments and come to a final decision whether to grant Emergency Use Listing to Covaxin." It added that the EUL process of WHO and the technical advisory group of independent experts is centred on determining if a manufactured vaccine is quality-assured, safe and effective.